| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | UNITED THERAPEUTICS CORP DEL | 28,974 | 3,923,000 | 0.62% | ||
| 2 | TENET HEALTHCARE CORP | 252,080 | 4,464,000 | 0.71% | ||
| 3 | LEXICON PHARMACEUTICALS INC | 332,300 | 4,765,000 | 0.76% | ||
| 4 | OWENS & MINOR INC NEW | 145,874 | 5,047,000 | 0.80% | ||
| 5 | IMPAX LABORATORIES INC | 534,311 | 6,759,000 | 1.07% | ||
| 6 | MOMENTA PHARMACEUTICALS INC | 756,765 | 10,103,000 | 1.61% | ||
| 7 | LIFEPOINT HEALTH INC | 164,714 | 10,789,000 | 1.72% | ||
| 8 | LABORATORY CORP AMER HLDGS | 83,900 | 12,037,000 | 1.91% | ||
| 9 | CIGNA CORPORATION | 84,270 | 12,345,000 | 1.96% | ||
| 10 | PERRIGO CO PLC | 247,340 | 16,421,000 | 2.61% | ||
| 11 | MCKESSON CORP | 115,200 | 17,080,000 | 2.72% | ||
| 12 | PATTERSON COS INC | 386,232 | 17,469,000 | 2.78% | ||
| 13 | INTEGRA LIFESCIENCES HLDGS CP COM NEW | 488,230 | 20,569,000 | 3.27% | ||
| 14 | BIO RAD LABS INC | 114,042 | 22,733,000 | 3.62% | ||
| 15 | MASIMO CORP | 258,218 | 24,081,000 | 3.83% | ||
| 16 | VERTEX PHARMACEUTICALS INC | 267,050 | 29,202,000 | 4.64% | ||
| 17 | GILEAD SCIENCES INC | 448,490 | 30,461,000 | 4.84% | ||
| 18 | SHIRE PLC | 180,761 | 31,494,000 | 5.01% | ||
| 19 | IRONWOOD PHARMACEUTICALS INC | 1,940,778 | 33,110,000 | 5.27% | ||
| 20 | ANTHEM INC | 204,610 | 33,838,000 | 5.38% | ||
| 21 | BOSTON SCIENTIFIC CORP | 1,423,880 | 35,412,000 | 5.63% | ||
| 22 | PERKINELMER INC | 623,408 | 36,195,000 | 5.76% | ||
| 23 | BRISTOL MYERS SQUIBB CO | 782,390 | 42,546,000 | 6.77% | ||
| 24 | BAXTER INTL INC | 1,036,233 | 53,739,000 | 8.55% | ||
| 25 | LILLY ELI & CO | 661,350 | 55,626,000 | 8.85% | ||
| 26 | ABBOTT LABS | 1,318,642 | 58,561,000 | 9.31% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001475373-17-000007, filed 2017.06.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
